Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function

Clinical trial NCT06823245 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06823245
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer

Start date: 2025-02-28
Primary completion: 2025-07-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.